Public Policy Resources

Share

As a recognized expert in cancer health policy, ACS CAN develops reports, white papers, testimony, fact sheets, regulatory comment letters and public policy on a wide range of issues related to preventing cancer and improving the health care system for persons with cancer and survivors.  We encourage you to use this resource to learn more about our issue priorities and policy work. If you can't find something you need, you may contact us by using our contact form and selecting Policy Resources from the drop-down menu.

Search for Resources

FILTER BY:

Photo of female cancer patient

Patient Quality of Life

ACS CAN advocates for policies that improve the lives of cancer patients by making treatment of their pain and other symptoms and coordination of their care standard protocol throughout their treatment for cancer, starting at the point of diagnosis.
 

Featured Resources

 

In the fall of 2018 the U.S. House and Senate passed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act.

Comment to ASPE on Opioids RFI - 2019-16145; Request for Information: Ensuring Patient Access and Effective Drug Enforcement.

ACS CAN submitted comments to FDA regarding the use of opioids at higher doses, in response to an FDA request for comments. 

Photo of ACS CAN Volunteers at Advocacy Event to Support Cancer Research Funding

Research, Funding and Drug Development

Improvements in outcomes for cancer patients require continued research and innovation.  ACS CAN advocates for robust federal funding for cancer research, as well as research and drug approval policies that accelerate the development of new treatments while still ensuring patient safety.

In October 2019 CMS revised its earlier National Coverage Decision (NCD) regarding Next-Generation Sequencing (NGS).  CMS recongized that its previous policy had unintended consequences with respect to germline testing and modified its policy.  While ACS CAN supports this policy change, several o

The National Program of Cancer Registries (NPCR) at the Centers for Disease Control and Prevention (CDC) provides technical, operational, and financial support to almost all state cancer registries to help ensure data collected are representative of the U.S. population.

Clinical trials are the key step in advancing potential new cancer treatments from the research setting to the cancer care clinic, and patient participation in trials is crucial to this success.

Photo of ACS CAN Volunteers participating in health care reform Lobby Day event

Access to Health Care

ACS CAN advocates for policies that provide access to treatments and services people with cancer need for their care - including those who may be newly diagnosed, in active treatment and cancer survivors.

ACS CAN comments on Utah's 1115 Demonstration Waiver.

ACS CAN Comments on Idaho's 1115 Demonstration Waiver.

ACS CAN Comments on Montana's 1115 Demonstration Waiver.

Photo of Making Strides Against Breast Cancer Event Participant

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Electronic cigarettes, or e-cigarettes, refer to a category of novel tobacco products that are typically battery-operated products designed to deliver a heated solution, or aerosol of nicotine and other chemicals, to the user

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) respectfully submit the following comments on the Food and Drug Administration’s (FDA’s) comprehensive, multi-year Nutrition Innovation Strategy.  

Flavors are a marketing weapon the tobacco manufacturers use to target youth and young people to a lifetime of addiction. The use of any flavored tobacco product among youth is concerning because it exposes them to a lifetime of nicotine addiction, disease, and premature death.